Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colistin Nephrotoxicity in Hospitalized Patients: The Role of Biomarkers in Guiding the Preventive Strategies

NCT07668141 is registered in ClinicalTrials.gov with Helwan University as lead sponsor.

NCT NCT07668141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07668141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colistin Nephrotoxicity in Hospitalized Patients: The Role of Biomarkers in Guiding the Preventive Strategies
Lead sponsor
Helwan University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
February 28, 2027
Enrollment
88 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

nephrotoxicity